Syringomyelia in the Cavalier King Charles spaniel (CKCS) dog.
Wolfe
Katheryn C
KC
Poma
Roberto
R
D000588:Amines / Q000627:therapeutic use; D000700:Analgesics / Q000627:therapeutic use; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001139:Arnold-Chiari Malformation / Q000150:complications / Q000235:genetics / Q000473:pathology / Q000662:veterinary; D001947:Breeding; D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use; D018450:Disease Progression; D004283:Dog Diseases / Q000188:drug therapy / Q000235:genetics* / Q000473:pathology*; D004285:Dogs; D005260:Female; D000077206:Gabapentin; D020022:Genetic Predisposition to Disease; D008297:Male; D010146:Pain / Q000188:drug therapy / Q000209:etiology / Q000662:veterinary*; D011241:Prednisone / Q000627:therapeutic use; D011379:Prognosis; D011788:Quality of Life; D012720:Severity of Illness Index; D013595:Syringomyelia / Q000150:complications / Q000235:genetics / Q000473:pathology / Q000662:veterinary*; D005680:gamma-Aminobutyric Acid / Q000627:therapeutic use
D000588:Amines; D000700:Analgesics; D000893:Anti-Inflammatory Agents; D003509:Cyclohexanecarboxylic Acids; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin; D011241:Prednisone